Literature DB >> 16516944

Differences in the chlorine reactivity of four microcystin analogues.

Lionel Ho1, Gretchen Onstad, Urs von Gunten, Stéphanie Rinck-Pfeiffer, Keith Craig, Gayle Newcombe.   

Abstract

The presence of microcystin toxins in drinking water is highly undesirable as they have the potential to adversely affect human health. Consequently, effective removal of these toxins from water is a major goal for water authorities. In this study, four microcystin analogues were chlorinated in two treated waters, and two of the analogues were chlorinated in deionised water. The oxidation of the microcystins was related to the chlorine exposure (CT) of the sample waters with the ease of oxidation following the trend: microcystin-YR > microcystin-RR > microcystin-LR > or = microcystin-LA. This trend was in agreement with published data on model compounds and free amino acids. Values of CT of up to 25 mg min L(-1) were required for oxidation of all microcystin analogues to below the World Health Organization guideline value of 1.0 microg L(-1). Results from this study indicate that for some water resources it is important to determine the speciation of the microcystin analogues to optimise chlorination practices.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516944     DOI: 10.1016/j.watres.2006.01.030

Source DB:  PubMed          Journal:  Water Res        ISSN: 0043-1354            Impact factor:   11.236


  2 in total

1.  Delayed Release of Intracellular Microcystin Following Partial Oxidation of Cultured and Naturally Occurring Cyanobacteria.

Authors:  Katherine E Greenstein; Arash Zamyadi; Caitlin M Glover; Craig Adams; Erik Rosenfeldt; Eric C Wert
Journal:  Toxins (Basel)       Date:  2020-05-20       Impact factor: 4.546

2.  UV-B Exposure Affects the Biosynthesis of Microcystin in Toxic Microcystis aeruginosa Cells and Its Degradation in the Extracellular Space.

Authors:  Zhen Yang; Fanxiang Kong
Journal:  Toxins (Basel)       Date:  2015-10-20       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.